Rising Losses Cloud Oneview Healthcare’s Growth Story in FY2025
Oneview Healthcare PLC reported a 21% increase in total revenue to €12 million for the year ended 31 December 2025, driven by growth in recurring revenue and customer expansion. Despite this, the company’s loss after tax widened to €12.6 million, reflecting ongoing investment and cost pressures.
- Total revenue up 21% to €12 million
- Recurring revenue increased 7% to €7.65 million
- Loss after tax widened to €12.6 million
- Live endpoints grew by 1,469 to 14,880
- No dividends declared; additional capital expected
Revenue Growth Driven by Recurring Income and Customer Expansion
Oneview Healthcare PLC, a healthcare software provider, has reported a solid 21% increase in total revenue for the year ended 31 December 2025, reaching €12 million. This growth was largely supported by a 7% rise in recurring revenue, which now accounts for €7.65 million of the total. The company’s platform was live across 14,880 endpoints at year-end, up by 1,469 from the previous year, reflecting ongoing customer adoption and expansion.
Losses Widen Amid Continued Investment and Cost Pressures
Despite the revenue gains, Oneview’s loss after tax increased to €12.6 million, compared to €10.8 million in 2024. The company continues to invest heavily in product development, including new offerings like digital whiteboards and mobile patient engagement tools. Operating expenses, particularly in product development and marketing, remain elevated as the company pursues growth and innovation.
Balance Sheet and Cash Flow Reflect Funding Needs
The company’s net tangible assets per share declined to €0.004 from €0.016 the previous year, highlighting the impact of accumulated losses. Cash reserves fell to €4.6 million from €13.8 million, with net cash used in operating activities at €8.4 million. Oneview has not declared any dividends and does not plan to do so, signalling a focus on reinvestment and growth.
Management Outlook and Capital Raising Plans
Management remains confident in the company’s growth trajectory, citing new customer wins and expansions within existing accounts. However, they acknowledge the need for additional capital to fund ongoing development and commercial objectives. The directors express a reasonable expectation of raising equity capital to support the business and maintain going concern status, though timing and amounts will depend on market conditions and investor sentiment.
Strategic Focus on Cost Discipline and Cash Flow Breakeven
Looking ahead, Oneview aims to exercise prudent control over operating expenses and identify efficiencies to move towards cash flow breakeven. The company’s investments in innovative healthcare software solutions position it well in a growing market, but balancing growth ambitions with financial discipline will be critical in the coming years.
Bottom Line?
Oneview’s strong revenue growth is encouraging, but investors will watch closely how the company manages costs and capital needs to achieve sustainable profitability.
Questions in the middle?
- When and how will Oneview secure the additional capital it needs?
- Can the company accelerate progress towards cash flow breakeven?
- How will competitive pressures and market conditions impact future growth?
